Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

Randomized, controlled trial of telcagepant over four migraine attacks

(2010) Andrew P Ho et al.   CEPHALALGIA

Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist

(2010) C. A. Salvatore et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist

(2010) Ian M. Bell et al.   ACS Medicinal Chemistry Letters

Randomized, controlled trial of telcagepant for the acute treatment of migraine

(2009) K. M. Connor et al.   NEUROLOGY

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

(2008) Tony W Ho et al.   LANCET

Calcitonin gene-related peptide (CGRP) antagonists and migraine: Is this a new era?

(2008) P. J. Goadsby   NEUROLOGY